# Atherosclerosis Monitoring and Atherogenicity Reduction Study

> **NCT01734707** · PHASE3 · COMPLETED · sponsor: **Institute for Atherosclerosis Research, Russia** · enrollment: 300 (actual)

## Conditions studied

- Carotid Atherosclerosis

## Interventions

- **DIETARY_SUPPLEMENT:** Allicor
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01734707
- **Lead sponsor:** Institute for Atherosclerosis Research, Russia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2005-01
- **Final completion:** 2005-10
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2012-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01734707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01734707, "Atherosclerosis Monitoring and Atherogenicity Reduction Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01734707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*